Table 1 Prevalence and demographic characteristics of triptan users and unmet medical needs (UMN) in migraineurs treated with triptans, for the overall cohort and stratified for subtypes according to the average triptan dose units per month
|  | Overall triptan users | Overall UMN migraineurs | Average triptan dose units per month in 1 year | ||
|---|---|---|---|---|---|
4–9 | 10–14 | > 14 | |||
pLF-EM | pHF-EM | pCM | |||
| Â | 82,446 | 31,515 | 22,796 | 5467 | 3252 |
Rate of triptan users (%) | 100 | 38.2 | 27.6 | 6.6 | 3.9 |
Rate of UMN migraineurs (%) | – | 100 | 72.3 | 17.4 | 10.3 |
Prevalence (per 1000 adult inhabitants) | 8.0 | 3.1 | 2.2 | 0.5 | 0.3 |
Gender | |||||
 Female (%) | 78.5 | 80.9 | 81.5 | 81.0 | 76.2 |
 Male (%) | 21.5 | 19.1 | 18.4 | 19.0 | 23.8 |
Age | |||||
 Mean ± SD | 47 ± 13 | 49 ± 11 | 48 ± 11 | 49 ± 11 | 50 ± 11 |
 Median | 47 | 48 | 48 | 48 | 49 |
 18–29 (%) | 9.8 | 5.0 | 5.5 | 3.6 | 4.0 |
 30–39 (%) | 18.0 | 14.4 | 15.8 | 14.0 | 12.1 |
 40–49 (%) | 32.0 | 36.2 | 33.0 | 37.1 | 35.4 |
 50–59 (%) | 24.1 | 28.6 | 27.7 | 29.5 | 29.8 |
 60–69 (%) | 10.9 | 11.7 | 13.5 | 11.5 | 13.0 |
 70–79 (%) | 3.9 | 3.5 | 3.9 | 3.5 | 4.8 |
 ≥ 80 (%) | 1.2 | 0.7 | 0.6 | 1.0 | 0.8 |